Preview Mode Links will not work in preview mode
  1. All Episodes
  2. Diffuse Large B-Cell Lymphoma | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Diffuse Large B-Cell Lymphoma

Diffuse Large B-Cell Lymphoma | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Diffuse Large B-Cell Lymphoma

Jan 8, 2024

Featuring perspectives from Prof Michael Dickinson, Prof Grzegorz S Nowakowski, Prof Gilles Salles, Dr Laurie H Sehn and Dr Jason Westin, including the following topics: 
 
• Introduction (0:00)
• Up-Front Management of Diffuse Large B-Cell Lymphoma (DLBCL) — Dr Salles (6:58)
• Promising Investigational Approaches to First-Line Therapy for DLBCL — Dr Nowakowski (25:27)
• Selection and Sequencing of Novel Therapies for Relapsed/Refractory (R/R) DLBCL — Dr Sehn (48:08)
• Incorporation of CAR T-Cell Therapy into the Management of R/R DLBCL — Dr Westin (1:18:15)
• Role of Bispecific Antibodies in the Treatment of DLBCL — Prof Dickinson (1:43:27)
 
CME information and select publications